NCT05487508View on ClinicalTrials.gov

Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2018

Primary Completion Date

January 31, 2019

Study Completion Date

March 31, 2019

Conditions
Coronary Artery DiseaseInflammatory Response
Interventions
DRUG

Dexamethasone

Administration of intraoperative 1 mg/kg body weight dexamethasone

DRUG

Normal saline

Placebo (NaCl 0.9%)

Trial Locations (1)

11420

National Cardiovascular Center Harapan Kita, Jakarta

All Listed Sponsors
lead

Indonesia University

OTHER

NCT05487508 - Efficacy of Dexamethasone to Improve Clinical Outcomes in Coronary Artery Bypass Patients | Biotech Hunter | Biotech Hunter